About the MIF

• For research projects which have already demonstrated a proof of concept in a controlled or laboratory setting.
• Whether the solution comes from the sciences, arts, engineering, medicine, music or agriculture, we invite you to apply.

• For research projects which have gone beyond the proof of concept, and that demonstrate a clear ability to implement, distribute, deliver and scale their solution.
• Each project must show a proven commercial potential for the advanced research to become either a spin-off or a licensed solution within 12-24 months.

• For projects which have already started to implement their commercialization plan and can demonstrate that they have the potential to go much further.
• The project has been deployed and requires support funding to reach new heights.
• Open to all McGill spinoffs.

Open to companies that are based on McGill University IP with a signed license agreement/equity arrangement with McGill in the last 5 years (i.e. 2018), OR to comanies in the process of signing a license agreement with McGill. Should the applicant be a successful recipient, the license agreement must be signed before any funding is released.

• For research projects with a clear plan to commercialize a patentable solution OR copyright
• Applicants cannot be incorporated
• TRL 3-4

• For advanced projects that are approaching commercialization
• Applicants can be incorporated
• TRL 5-6

• For projects already being commercialized as a spin-off
• Applicants must be incorporated
• TRL 7+

• Advance a patentable solution OR a copyright
• To prepare your project to:
  • Be commercialized
  • Be implemented in the world
  • Create a positive impact
• The application must demonstrate:
  • The positive impact the project will generate (commercial, medical, social, environmental)
  • A clear timeline on how this funding will enable you to transform the project from research to a deliverable solution
  • That your team is capable and willing to take the project outside the university
  • That the funds would truly contribute to advancing the research to become a ‘real-world’ solution

• An approved Report of Invention with McGill I+P
• A detailed budget for how you will use the funding
• Component or software ready to validate in a laboratory setting
• A clear timeline to implementation

• Advance a filed patent application OR a commercially viable copyright
• To prepare your project to: become a spin-off OR be licensed
• The application must demonstrate:
  • Clear proof of concept that the project is viable and scalable
  • That the project is advanced enough to be commercialized or licensed
  • The commercial value the project will generate
• A clear timeline on how this funding will enable you will deliver the solution (licensing? Spin-off?)
• That your team is capable and willing to take the project outside the university and beyond
• That the funds would truly contribute to transforming the research into a commercially viable project within 12-months

• An approved Report of Invention with McGill I+P;
• Protected intellectual property (patent application or copyright)
• A detailed budget for how you will use the funding
• A demonstrated ability to deliver your project as a spin-off or license
• A clearly defined target: market, audience, problem
• Business strategy / strategic plan to get to market

• Deliver a licensed technology for commercial purposes
• Grow a McGill spin-off
• Raise more capital
• The application must demonstrate:
  • That the spinoff is an appropriate vehicle to bring the technology to market
  • How this funding will enable the spinoff to:
    • Begin commercialization
    • Increase market share
    • Go international
    • Create bigger impact
    • Or all of the above
  • That your team is capable and willing to take the project to the next level
  • That the funds would truly fill an essential funding gap needed for the spin-off to grow

• A license agreement or equity arrangment with McGill I+P based on a McGill Report of Invention; agreement must have been signed within the last 5 years OR in the process of signing a license agreement with McGill. Should the applicant be a successful recipient, the license agreement must be signed before any funding is released.
• A detailed budget for how you will use the funding
• Clear market potential to generate commercial returns
• Confirmed sales or a letter of intent from an interested client/partner/licensee
• Core team in place
• A 12-month action plan

Teams in this category will make a second pitch to judges which will be evaluated based on two main factors:

• Potential to prevent, diagnose and/or treat life-threatening bacterial infections
• Ability of the team to realize that impact